Cross-talk between SARS-CoV-2 infection and the insulin/IGF signaling pathway: Implications for metabolic diseases in COVID-19 and for post-acute sequelae of SARS-CoV-2 infection
Related Posts
Paras ML, Stead W, Bisono-Garcia B, Pottinger PS, Aziz R, Aziz M, Balba GP, Blackburn BG, Butt S, Chow B, Graber CJ, Muñoz-Gomez S, Pellegrino[...]
Tewari SE, Hoffman R, Lockman S, Flanagan CF, Webb KA, Horsfall S, Chimwaza A, Dugdale CM, Currier J, Dhodho E, Neilan AM, Masiye K, Rana[...]
Foldyna B, Hadzic I, Mayrhofer T, Karády J, Taron J, Kolossváry M, Raghu VK, McCallum S, Paradis K, Diggs MR, Chu SM, Lu AB, Somboonwit[...]